Hemophilia B

Disease State Hub

News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Commentary Podcasts Q&As Videos
Interactive
Polls Quizzes Slideshows
Events & Education

FDA Alerts

FDA Alerts
FDA Alerts
FDA Approves Adalimumab Biosimilar
09/26/2016
The FDA approved the biosimilar adalimumab-atto for the treatment of inflammatory diseases including RA, psoriatic arthritis, and Crohn's disease.
09/26/2016
FDA Alerts
FDA Alerts
FDA Approves New Option for Type 2 Diabetes (INVOKAMET XR)
09/21/2016
The FDA has approved INVOKAMET XR for use as a supplement to diet and exercise for improved control of blood glucose levels in adults with type 2 diabetes.
09/21/2016
FDA Alerts
FDA Alerts
FDA Approves New Option for Type 2 Diabetes (INVOKAMET XR)
09/21/2016
The FDA has approved INVOKAMET XR for use as a supplement to diet and exercise for improved control of blood glucose levels in adults with type 2 diabetes.
09/21/2016
FDA Alerts
FDA Alerts
FDA Approves New Option for Type 2 Diabetes (INVOKAMET XR)
09/21/2016
The FDA has approved INVOKAMET XR for use as a supplement to diet and exercise for improved control of blood glucose levels in adults with type 2 diabetes.
09/21/2016
FDA Alerts
FDA Alerts
FDA Approves New Option for Secondary CV Prevention
09/15/2016
The FDA approved Yosprala to treat patients who need aspirin for secondary prevention of cardiovascular and cerebrovascular events.
09/15/2016
FDA Alerts
FDA Alerts
FDA Approves New Option for Secondary CV Prevention
09/15/2016
The FDA approved Yosprala to treat patients who need aspirin for secondary prevention of cardiovascular and cerebrovascular events.
09/15/2016
FDA Alerts
FDA Alerts
FDA Approves New Option for Secondary CV Prevention
09/15/2016
The FDA approved Yosprala to treat patients who need aspirin for secondary prevention of cardiovascular and cerebrovascular events.
09/15/2016
Medication Prescribing
Medication Prescribing
FDA Issues Strong Warnings Against Combining Opioids and Benzodiazepine
09/01/2016
The FDA is requiring boxed warnings for opioid analgesics and prescription opioid cough products related to combined use of certain opioids with benzodiazepines.
09/01/2016
Medication Prescribing
Medication Prescribing
FDA Issues Strong Warnings Against Combining Opioids and Benzodiazepine
09/01/2016
The FDA is requiring boxed warnings for opioid analgesics and prescription opioid cough products related to combined use of certain opioids with benzodiazepines.
09/01/2016
Medication Prescribing
Medication Prescribing
FDA Issues Strong Warnings Against Combining Opioids and Benzodiazepine
09/01/2016
The FDA is requiring boxed warnings for opioid analgesics and prescription opioid cough products related to combined use of certain opioids with benzodiazepines.
09/01/2016